BARCLAYS PLC

Position in TCRT — Alaunos Therapeutics, Inc.

CIK 312069 LONDON, X0

Position in TCRT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$33

-$87 QoQ

Shares Held

-70.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#24

of 29 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,595 across 454 Biotechnology names. TCRT ranks #444 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$33	15	-70.0%	Shares	Defined	2026-08-14
2025-09-30	$120	50	-50.0%	Shares	Sole	2026-03-31
2025-06-30	$485	100	-41.5%	Shares	Sole	2026-02-27
2025-03-31	$251	171	-99.9%	Shares	Sole	2026-03-17
2022-09-30	$234,153	136,136	+288.7%	Shares	Sole	2022-11-03
2022-03-31	$22,767	35,027	-86.2%	Shares	Sole	2022-05-16
2021-12-31	$277,333	254,434	+193.1%	Shares	Sole	2022-02-14
2021-09-30	$157,981	86,803	+188.8%	Shares	Sole	2021-11-09
2021-06-30	$79,344	30,055	-83.4%	Shares	Sole	2021-08-13
2021-03-31	$650,098	180,583	+152.5%	Shares	Sole	2021-05-13
2020-12-31	$180,234	71,522	-26.6%	Shares	Sole	2021-02-11
2020-09-30	$245,667	97,487	-18.6%	Shares	Sole	2020-11-12
2020-06-30	$392,884	119,782	+84.9%	Shares	Sole	2020-08-12
2020-03-31	$158,684	64,769	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.